Iovance Biotherapeutics, Inc. (IOVA)

NASDAQ: IOVA · IEX Real-Time Price · USD

9.25

-0.18 (-1.91%)

At close: Jul 26, 2024, 4:00 PM

9.29

+0.04 (0.43%)

After-hours: Jul 26, 2024, 7:28 PM EDT

Iovance Biotherapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2013
Revenue	1.9	1.19	-	-	-	-	Upgrade
Cost of Revenue	18.02	10.76	-	-	-	-	Upgrade
Gross Profit	-16.11	-9.57	-	-	-	-	Upgrade
Selling, General & Admin	110.19	106.92	104.1	83.66	60.21	40.85	Upgrade
Research & Development	341.13	344.08	294.78	259.04	201.73	166.02	Upgrade
Operating Expenses	451.31	450.99	398.88	342.7	261.94	206.87	Upgrade
Operating Income	-467.43	-460.56	-398.88	-342.7	-261.94	-206.87	Upgrade
Interest & Investment Income	7.93	9.44	3.46	6.46	4.22	5.9	Upgrade
EBT Excluding Unusual Items	-459.49	-451.12	-395.42	-336.24	-257.72	-200.98	Upgrade
Gain (Loss) on Sale of Investments	4.96	3.61	-0.47	-6.01	-1.87	3.42	Upgrade
Pretax Income	-454.53	-447.52	-395.89	-342.25	-259.58	-197.56	Upgrade
Income Tax Expense	-4.89	-3.48	-	-	-	-	Upgrade
Net Income	-449.64	-444.04	-395.89	-342.25	-259.58	-197.56	Upgrade
Net Income to Common	-449.64	-444.04	-395.89	-342.25	-259.58	-197.56	Upgrade
Shares Outstanding (Basic)	248	235	159	153	138	124	Upgrade
Shares Outstanding (Diluted)	248	235	159	153	138	124	Upgrade
Shares Change (YoY)	43.17%	47.64%	3.82%	10.92%	11.23%	27.82%	Upgrade
EPS (Basic)	-1.81	-1.89	-2.49	-2.23	-1.88	-1.59	Upgrade
EPS (Diluted)	-1.81	-1.89	-2.49	-2.23	-1.88	-1.59	Upgrade
Free Cash Flow	-405.08	-384.11	-313.18	-265.52	-251.93	-165.81	Upgrade
Free Cash Flow Per Share	-1.63	-1.63	-1.97	-1.73	-1.82	-1.33	Upgrade
Operating Margin	-24549.63%	-38734.99%	-	-	-	-	Upgrade
Free Cash Flow Margin	-21275.26%	-32305.30%	-	-	-	-	Upgrade
EBITDA	-451.03	-449.01	-389.57	-339.59	-260.8	-205.7	Upgrade
D&A For EBITDA	16.39	11.55	9.31	3.11	1.14	1.17	Upgrade
EBIT	-467.43	-460.56	-398.88	-342.7	-261.94	-206.87	Upgrade
Revenue as Reported	1.9	1.19	-	-	-	-	Upgrade

Source: S&P Capital IQ. Standard template.